Search by Drug Name or NDC
NDC 00409-9094-25 Fentanyl Citrate 50 ug/mL Details
Fentanyl Citrate 50 ug/mL
Fentanyl Citrate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is FENTANYL CITRATE.
Product Information
| NDC | 00409-9094 |
|---|---|
| Product ID | 0409-9094_dd044413-7ca2-42d5-8d0d-781d2db4982c |
| Associated GPIs | 65100025102012 65100025102037 65100025102032 65100025102022 65100025102042 |
| GCN Sequence Number | 041385 |
| GCN Sequence Number Description | fentanyl citrate/PF VIAL 50 MCG/ML INJECTION |
| HIC3 | H3H |
| HIC3 Description | OPIOID ANALGESIC, ANESTHETIC ADJUNCT AGENTS |
| GCN | 32807 |
| HICL Sequence Number | 025386 |
| HICL Sequence Number Description | FENTANYL CITRATE/PF |
| Brand/Generic | Generic |
| Proprietary Name | Fentanyl Citrate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | FENTANYL CITRATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | ug/mL |
| Substance Name | FENTANYL CITRATE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| Marketing Category | NDA |
| Application Number | NDA019115 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-9094-25 (00409909425)
| NDC Package Code | 0409-9094-25 |
|---|---|
| Billing NDC | 00409909425 |
| Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-25) / 5 mL in 1 VIAL, SINGLE-DOSE (0409-9094-18) |
| Marketing Start Date | 2005-11-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |